
Bioorganic and Medicinal Chemistry Letters p. 1791 - 1796 (1998)
Update date:2022-09-26
Topics:
Chambers
Antognoli
Cheng
Marfat
Pillar
Shirley
Watson
By addressing the issues of potency and metabolism in 3, a new series of LTD4 antagonists represented by (+)-26 was developed which is equipotent to clinical LTD4 antagonists Zafirlukast (1) and Pranlukast (2).
View MoreShangHai BMG Chemical Co., Ltd
Contact:+86-13524845543
Address:Room 602, no 291 sikai road shanghai
PharmaResources(Kaiyuan)CO,.Ltd
Contact:+86-21-50720028
Address:No.3, Beihuan Road, Economic Development District, Kaiyuan City, Tieling City, Liaoning Province, China 112300
Disynthesis Chemical Technology Co. Ltd.
Contact:+86-571-88194596
Address:Dengyun road 380, Gongshu district, Hangzhou city, China
Hebei Tianxiang Biological & Pharmaceutical Co., Ltd
Contact:86-0312-6615158
Address:No 42 fazhan street qingyuan county
Chemsigma International Co.,Ltd.
website:http://www.chemsigma.com
Contact:86-025-58748998
Address:Rm.705, 15th Building,Rd.Xinke II
Doi:10.1016/S0040-4039(97)01002-2
(1997)Doi:10.1039/a807718e
(1999)Doi:10.1002/hlca.19970800424
(1997)Doi:10.1021/acs.organomet.7b00603
(2018)Doi:10.1016/S0040-4020(97)00526-7
(1997)Doi:10.1021/jo970548x
(1997)